Hypolipidemic Agents

22 books

Lipid disordersJames Shepherd

⏱ 4h 22m

Lipid disorders

James Shepherd

2004262 pp.

Lipid-lowering therapy and progression of coronary atherosclerosisA. V. Bruschke

⏱ 3h 51m

Lipid-lowering therapy and progression of coronary atherosclerosis

A. V. Bruschke

1899231 pp.

Biofluid and tissue analysis for drugs, including hypolipidaemicsEric Reid

⏱ 7h 0m

Biofluid and tissue analysis for drugs, including hypolipidaemics

Eric Reid

1994420 pp.

The Management of Lipids in Clinical PracticeNeil J. Stone

⏱ 5h 16m

The Management of Lipids in Clinical Practice

Neil J. Stone

1997316 pp.

Drugs affecting lipid metabolismInternational Symposium on Drugs Affecting Lipid Metabolism (7th 1980 Milan, Italy)

⏱ 6h 34m

Drugs affecting lipid metabolism

International Symposium on Drugs Affecting Lipid Metabolism (7th 1980 Milan, Italy)

1980394 pp.

Drugs affecting lipid metabolismRodolfo Paoletti

⏱ 7h 42m

Drugs affecting lipid metabolism

Rodolfo Paoletti

1967462 pp.

Hyperlipidemia (Fast Facts)Paul N. Durrington

⏱ 2h 38m

Hyperlipidemia (Fast Facts)

Paul N. Durrington

2005158 pp.

Therapeutic selectivity and risk/benefit assessment of hypolipidemic drugsGiorgio Ricci

⏱ 5h 29m

Therapeutic selectivity and risk/benefit assessment of hypolipidemic drugs

Giorgio Ricci

1982329 pp.

HyperlipidaemiaPaul N. Durrington

⏱ 1h 55m

Hyperlipidaemia

Paul N. Durrington

2000115 pp.

AtherosclerosisArnold von Eckardstein

⏱ 13h 36m

Atherosclerosis

Arnold von Eckardstein

2005816 pp.

StatinsJ. Shepherd

⏱ 5h 4m

Statins

J. Shepherd

2004304 pp.

Drugs affecting lipid metabolism XInternational Symposium on Drugs Affecting Lipid Metabolism (10th 1989 Houston, Tex.)

⏱ 9h 35m

Drugs affecting lipid metabolism X

International Symposium on Drugs Affecting Lipid Metabolism (10th 1989 Houston, Tex.)

1990575 pp.

Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agentsSymposium on New Drugs and Devices (9th 1988 Philadelphia, Pa.)

⏱ 5h 1m

Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents

Symposium on New Drugs and Devices (9th 1988 Philadelphia, Pa.)

1989301 pp.

Cardiovascular drugsGraeme S. Avery

⏱ 2h 56m

Cardiovascular drugs

Graeme S. Avery

1978176 pp.

Drugs Affecting Lipid Metabolism VIIIDavid Kritchevsky

⏱ 8h 22m

Drugs Affecting Lipid Metabolism VIII

David Kritchevsky

1985502 pp.

Guidelines for the clinical evaluation of lipid-altering agents in adults and childrenUnited States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products

⏱ 10m

Guidelines for the clinical evaluation of lipid-altering agents in adults and children

United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products

198010 pp.

Clinicians' guide to lipids and coronary heart diseaseD. J. Betteridge

⏱ 6h 24m

Clinicians' guide to lipids and coronary heart disease

D. J. Betteridge

2003384 pp.

Hypolipidemic agentsDavid Kritchevsky

⏱ 8h 8m